Petros Pharmaceuticals, Inc. (PTPI)
Sells software that helps pharmaceutical companies manage drug development and operations.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-87.5%
The outlook
PTPI is trading near its 52-week lows, well below both its 50- and 200-day moving averages. Analyst coverage appears minimal, and the stock shows a bearish sentiment score. The current price sits just 6% of the way up from its yearly low point.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Market cap
$169,489
52-wk high
$0.03
52-wk low
$0.00
50-day avg
$0.01
200-day avg
$0.01
Trailing P/E
0.0